MiR-27b-5p promotes gastric cancer progression by targeting CREBZF to regulate the STAT3 pathway

doi:10.4251/wjgo.v18.i3.113781

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 3

This Article

(27)

(29)

(0)

(8)

(486)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Oncol. Mar 15, 2026; 18(3): 113781
Published online Mar 15, 2026. doi: 10.4251/wjgo.v18.i3.113781

Full Size Figure Download Figure

Figure 1 Comparative expression of miR-27b-5p in gastric cancer tissue and its effect for gastric cancer cell lines. A: Expression of miR-27b-5p in 15 gastric cancer and adjacent non-cancer tissue; B and C: Expression of miR-27b-5p and overall survival in gastric cancer based on The Cancer Genome Atlas-STAD dataset; D: Expression of miR-27b-5p and proliferation of AGS cell line following the miR-27b-5p interference; E: Expression of miR-27b-5p and proliferation of NCI-N87 cell line following the miR-27b-5p interference. ^bP < 0.01. NC: Negative control; OD: Optical density.

Citation: Ma FC, Zhang GL, Chen GQ, Ling JW, Li YF, Chi BT, Tang YL, Peng W, Chen G, Wei DM, Rong MH, Ge LY. MiR-27b-5p promotes gastric cancer progression by targeting CREBZF to regulate the STAT3 pathway. World J Gastrointest Oncol 2026; 18(3): 113781
URL: https://www.wjgnet.com/1948-5204/full/v18/i3/113781.htm
DOI: https://dx.doi.org/10.4251/wjgo.v18.i3.113781

Ma FC, Zhang GL, Chen GQ, Ling JW, Li YF, Chi BT, Tang YL, Peng W, Chen G, Wei DM, Rong MH, Ge LY. MiR-27b-5p promotes gastric cancer progression by targeting CREBZF to regulate the STAT3 pathway. World J Gastrointest Oncol 2026; 18(3): 113781 [DOI: 10.4251/wjgo.v18.i3.113781]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.